The present invention relates to triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione; metalloproteinase inhibitors of the formula ##STR00001## wherein X, A, Y, B, G, W, and R.sup.1 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.

 
Web www.patentalert.com

< Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates

< Process for the preparation of tolterodine and intermediates thereof

> Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

> Antitumor effect potentiators
~ 00293